Daiichi Sankyo starts Ph 1 Trial for Nafamostat Inhalation Formulation to treat COVID-19

Therapeutics |  News | 0 Comment | 05 Apr, 2021

Daiichi Sankyo, based in Japan, has announced that it has initiated in Japan a first-in-human phase 1 trial for nafamost...Read more

Korea invents soft brain implant for treating neuro diseases

Therapeutics |  News | 0 Comment | 01 Apr, 2021

Researchers have invented a smartphone-controlled soft-brain implant that can be recharged wirelessly from outside the b...Read more

Australia's Starpharma's launches COVID-19 antiviral nasal spray VIRALEZE in the UK

Therapeutics |  News | 0 Comment | 01 Apr, 2021

Melbourne-based biotech Starpharma has launched its antiviral nasal spray VIRALEZE™ into the UK via a large nation...Read more

Gracell Bio leverages Lonza's expertise in CAR-T cell therapy manufacturing

Therapeutics |  News | 0 Comment | 01 Apr, 2021

China based Gracell Biotechnologies Inc., a global clinical-stage biopharmaceutical company dedicated to discovering and...Read more

Singapore creates 3D models to fine-tune radiation dose for nasopharyngeal cancer

Therapeutics |  News | 0 Comment | 31 Mar, 2021

Singapore, A*STAR’s Institute of Bioengineering and Nanotechnology (IBN) has teamed up with Singapore Institute of...Read more

Bright Peak Therapeutics and Ajinomoto to create novel immunocytokines

Therapeutics |  News | 0 Comment | 26 Mar, 2021

Bright Peak Therapeutics Inc., a biotechnology company developing next-generation immunotherapies for cancer and autoimm...Read more

POSTECH produces artificial lung model using 3D printing

Therapeutics |  News | 0 Comment | 25 Mar, 2021

Scientists at the Pohang University of Science and Technology (POSTECH) in South Korea have succeeded in producing ...Read more

Singapore SMART researchers develop rapid immune-profiling assay

Therapeutics |  News | 0 Comment | 25 Mar, 2021

Researchers from Critical Analytics for Manufacturing Personalized-Medicine (CAMP), an Interdisciplinary Research...Read more

Singapore study reveals variation in SARS-CoV-2 neutralizing antibody longevity

Therapeutics |  News | 0 Comment | 24 Mar, 2021

Scientists from Duke-NUS Medical School, the National Centre for Infectious Diseases (NCID) and the Agency for Science, ...Read more

Singapore develops AI platform to assess blood vessel anomalies

Therapeutics |  News | 0 Comment | 24 Mar, 2021

An international team of scientists from Nanyang Technological University, Singapore (NTU Singapore), Brown Un...Read more

Australia invests $2.6 M in life-improving research for brain cancer survivors

Therapeutics |  News | 0 Comment | 23 Mar, 2021

The Australian government is providing $2.6 million to researchers at the University of Melbourne to use the latest info...Read more

Singapore finds way to improve treatment outcomes for breast cancer

Therapeutics |  News | 0 Comment | 19 Mar, 2021

Breast cancer is the most common cancer in women worldwide and the second most common cancer overall. Although...Read more

Cancer drug delivery system receives US FDA approval for trials

Therapeutics |  News | 0 Comment | 18 Mar, 2021

A first-in-class cancer drug delivery system developed by Taiwan's National Health Research Institutes (NHRI) has receiv...Read more

Korea identifies genetic pathway that suppresses neurodegenerative diseases

Therapeutics |  News | 0 Comment | 17 Mar, 2021

Nucleocytoplasmic transport (NCT) defects have been implicated in neurodegenerative diseases, such as C9ORF72-associated...Read more

Govt launches $15 M grant for development of innovative therapies for mental illness

Therapeutics |  News | 0 Comment | 17 Mar, 2021

The Australian government is launching a $15 million competitive grant round to kick start Australian clinical trials ex...Read more

Singapore identifies chemotherapy-resistant cancers’ escape mechanism

Therapeutics |  News | 0 Comment | 16 Mar, 2021

ETC-159, a made-in-Singapore anti-cancer drug that is currently in early phase clinical trials for use in a subset ...Read more

Fujitsu, Kyoto University build AI system to detect genetic disorders

Therapeutics |  News | 0 Comment | 15 Mar, 2021

Fujitsu Limited and Kyoto University research group led by Professor Yasushi Okuno of the Kyoto University Graduate Scho...Read more

HSA approves first commercial CAR-T therapy by Novartis

Therapeutics |  News | 0 Comment | 10 Mar, 2021

Novartis has announced that Singapore Health Sciences Authority (HSA) has approved Kymriah (tisagenlecleucel) as th...Read more